The hypoxia-inducible factor (HIF)-1a, which has a major role in cell adaptation to hypoxia, is mainly regulated at post-translational levels. Recently, HIF-1a mRNA was also shown to be upregulated by several signal pathways under normoxic conditions. Here we focused on relationships of HIF-1a with NF-kB and b-catenin signaling in endometrial carcinomas (Em Cas). Long-term exposure of Ishikawa cells to cobalt chloride (CoCl 2 ), which is known to mimic the effect of hypoxia, caused a decrease in the growth, along with increased HIF-1a protein but not mRNA expression. In contrast, short-term exposure resulted in a rapid and transient increase in HIF-1a mRNA expression along with stabilization of nuclear NF-kB/p65 (p65). Transfection of p65 increased HIF-1a expression through activation of the promoter, whereas overexpression of HIF-1a also activated NF-kB-dependent transcription, indicating the existence of a positive feedback loop. In addition, HIF-1a was indirectly associated with nuclear b-catenin through interactions with p300, leading to slight enhancement of both HIF-1a-and b-catenin-mediated transcriptional activity. In clinical samples, biphasic upregulation of HIF-1a expression was observed in normal endometrial glandular components during the menstrual cycle, with the labeling indices showing significantly higher values in the early secretory stage. Significantly higher values for phosphorylated p65 and nuclear b-catenin were also observed in HIF-1a-positive than -negative lesions of Em Cas, in contrast to significantly lower Ki-67 status. These data therefore suggest that transcriptional associations with HIF-1a and NF-kB, as well as b-catenin/p300 complexes, may contribute to modulation of changes in tumor cell kinetics in response to a hypoxic condition in Em Cas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.